Pfizer emphasizes need for vigilance against pneumococcal disease; launches vaccine for adults Pfizer Inc. has officially launched in the Philippines its pneumococcal vaccine for adults aged 50 years old and above, amid statistics showing that pneumonia, the most common type of pneumococcal disease, is still the leading cause of morbidity and the 5th leading cause…
